(PharmaNewsWire.Com, November 01, 2017 ) Oxygen Therapy devices are useful specially for people suffering from severe COPD or cystic fibrosis who suffer from chronically low oxygen levels in their body. Advantages of oxygen therapy also include increased mental stamina, aversion of heart failure, and an enhanced breathing pattern. The administration and supply of supplementary oxygen have turned into an indispensable part in the management of numerous diseases. Furthermore, oxygen therapy is applicable to numerous diseases, for example, asthma, respiratory distress syndrome, and obstructive sleep apnoea. Long-term oxygen treatments in patients suffering from chronic lung disease are believed to enhance the length and the quality of life.
The growth of the Middle East and Africa oxygen therapy market is mainly driven by factors such as technological advancements, upsurge in frequency of COPD case and favourable government schemes. The growing need for better health care is another major factor driving the growth of the market. Be that as it may, poor compensation and major influence of private industries in health care is soaring the prices for treatment. Weak economy and purchasing power of people is further going to hamper the growth of the market. Despite the fact that the Middle East and Africa oxygen therapy devices market is expecting hindrances, it will discover new development opportunities in growing economies. Furthermore, better regimes and government's initiative towards improving health care are predicted to profit the Middle East and Africa oxygen therapy devices market.
The Middle East and Africa oxygen therapy devices market is segmented into product type, application and end user. On the basis of product, it is segmented into Oxygen Source Equipment, Cylinders, Concentrators, Liquid Oxygen Devices, PAP, Oxygen Delivery Device, Masks, Nasal Cannula, Venturi Mask, Non-Rebreather Mask, Bag Valve and CPAP. Oxygen source equipment are expected to grow at 11% CAGR It is attributed to the consolidation of this equipment in the extensive variety of uses as the first line of treatment. On the basis of application, it is segmented into Chronic Obstructive Pulmonary Disease, Asthma, Obstructive Sleep Apnoea, Respiratory Distress Syndrome, Cystic Fibrosis, Pneumonia. Chronic obstructive pulmonary disease holds the largest share of the application segment and it is anticipated to grow lucratively at a CAGR of over 10.5% over the next five years. This is due to increasing popularity of supplemental administration in conjunction with first line treatments available for COPD. Moreover, this treatment includes faster response rates, reliability and portability, and above all improves chances of survival. On the basis of end use it is segmented into Home Healthcare and Hospitals. Home health care dominates the end-use segment, owing to the rise in elderly population coupled with increasing number of patients with low mobility and long-term care requirement in conditions such as Alzheimer’s disease.
The Middle East and Africa region is geographically segmented into Middle East and Africa. The private sector plays a key role in funding the healthcare sector in Africa, with more than 50% of the investment being undertaken by them. The medical imaging market is growing slowly because of many problems the region faces, in terms of battles and also, the unstable economy. However, countries like the USA, China and UK are investing in the region and this increased financial revenue will aid the healthcare sectors in this region. This market is extremely disjointed with numerous big and developing players operating in the business. The major companies dominating the oxygen therapy devices market in this region are CareFusion, Tecno-Gaz Industries, GE Healthcare, DeVilbiss Healthcare, Philips Respironics, MAQUET Medical Systems, Allied Healthcare Products, Smiths Medical, Fisher & Paykel Healthcare, Invacare Corporation, Teleflex Incorporated and Smiths Medical
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and sksillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
